Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 27, 2025

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

11.9K

Krox20 expression in abnormal scars: An immunohistochemical study.

Ola A Bakry1, Rehab M Samaka2, Nansy Fayez1

  • 1Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Shebin El Kom, Egypt.

Journal of Cosmetic Dermatology
|April 13, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Autophagy-Related Gene 5 (ATG5) With Neonatal Cholestasis in Egyptian Pediatric Patients.

Iranian journal of pathology·2025
Same author

Antioxidant Potential of Selected Apiaceae Plant Extracts: A Study Focused on the Chemical Composition and Neuroprotective Effect of Coriandrum sativum L. Extract Against Lead (Pb)-Induced Neurotoxicity in Rats.

Biological trace element research·2025
Same author

Serum and Tissue Lipocalin-2 Expression in Chronic Kidney Disease Pruritic Patients.

Applied immunohistochemistry & molecular morphology : AIMM·2023
Same author

Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks.

Journal of cosmetic dermatology·2023
Same author

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway.

Scientific reports·2022
Same author

Immunohistochemical expression of Axin-2, as an implication of the role of stem cell in scar pathogenesis and prognosis.

Journal of cosmetic dermatology·2022
Same journal

Evaluation of a Novel Bimodal-Approach Radiofrequency Device for Lower Facial Tightening in Southeast Asian Patients: An Open-Label Prospective Study.

Journal of cosmetic dermatology·2026
Same journal

Global Publication Trends and Advances in Striae Distensae Research: A Bibliometric Analysis.

Journal of cosmetic dermatology·2026
Same journal

Supraumbillical Skin Retraction After Laser Assisted Liposuction/Lipolysis.

Journal of cosmetic dermatology·2026
Same journal

Chlorella Polysaccharide Extract Attenuates Skin Aging via MAPK Pathway Suppression: Implications for Cosmetic Dermatology.

Journal of cosmetic dermatology·2026
Same journal

Similarities and Differences in the Perception of Artificially Modified Faces Between Caucasian and Chinese Observers.

Journal of cosmetic dermatology·2026
Same journal

Evaluation of Tissue Response to Coinjection Versus Individual Injection of Hyaluronic Acid Filler and Polycaprolactone Microsphere-Based Filler in a Rabbit Model.

Journal of cosmetic dermatology·2026
See all related articles

Krox20 is downregulated in scar epidermis but overexpressed in fibroblasts, particularly in keloids. This suggests Krox20 inhibition could be a novel therapeutic strategy for abnormal scarring.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Wound Healing Research

Background:

  • Scars result from the healing process and include keloids, hypertrophic scars, and atrophic scars.
  • Krox20 plays a role in skin and hair conditions, influencing collagen production and myofibroblast differentiation.
  • Krox20 is essential for transforming growth factor-beta (TGF-β)-induced profibrotic responses.

Purpose of the Study:

  • To investigate the role of Krox20 in the pathogenesis of abnormal scars.
  • To explore Krox20 as a potential target for new therapeutic strategies for scar treatment.

Main Methods:

  • The study analyzed 30 scar biopsies (keloids, atrophic, hypertrophic) and 10 healthy controls.
  • Immunohistochemical techniques were used to evaluate Krox20 expression in skin biopsies.
Keywords:
Krox20atrophic scarhypertrophic scarkeloidscars

More Related Videos

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
07:40

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

3.0K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.8K

Related Experiment Videos

Last Updated: Sep 27, 2025

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

11.9K
Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
07:40

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

3.0K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.8K
  • Krox20 expression was compared between scar types and healthy skin.
  • Main Results:

    • Krox20 was downregulated in the epidermis of scar tissues compared to normal skin (p=0.02).
    • Krox20 was significantly overexpressed in fibroblasts within scar tissues (p<0.001).
    • Keloid fibroblasts showed higher Krox20 expression than hypertrophic scar fibroblasts (p<0.001).

    Conclusions:

    • Krox20 overexpression in scar fibroblasts may contribute to scar pathogenesis.
    • Upregulation of Krox20 is linked to genes involved in tissue remodeling and wound healing.
    • Inhibiting Krox20 presents a potential new therapeutic avenue for managing abnormal scars.